Ozette in the news.

Read all about what we’ve been up to in our latest news and recent publications.

Ozette announces new partnership with Bloodworks Northwest.

The partnership will allow Bloodworks Northwest subsidiary, Bloodworks Bio, to leverage Ozette’s Lab and proprietary immune cell population discovery and annotation platform. The partnership will facilitate establishing a ‘gold standard’ in the advancement of cell therapies.

Read More

Ozette’s Cherie Green featured on Bloodworks Northwest podcast.

Listen in as Cherie discusses Ozette’s new partnership with Bloodworks Northwest.

Listen Now

Ozette announces new partnership with Umoja Biopharma.

Leveraging Ozette’s proprietary immune cell population discovery and annotation platform, Umoja will be working to discover novel oncology insights in preclinical models.

Read More

Ozette announces new suite of machine learning-powered computational analysis solutions.

SEATTLE–(BUSINESS WIRE)–Ozette Technologies, Inc., a technology-driven life sciences company, announces the launch of their Assay-to-Insights product, a streamlined, state-of-the-art process to explore the immune system in fresh and frozen samples. Ozette Assay-to-Insights combines three technologies developed by the company: world-class data generation at the Ozette Laboratory under Good Clinical Laboratory Practices (GCLP) guidelines; rapid computational monitoring of pre-defined biomarker endpoints using Ozette Endpoints™; and unbiased discovery and annotation of single-cell cytometry data through Ozette Discovery™. Insights generated from Ozette Endpoints™ and Ozette Discovery™ are made available through the Ozette Platform™, a cloud-based system that enables clinical teams to interact and explore cytometry data in a central dashboard.

Read More

Meet team Ozette at CYTO 2023 | May 20-24.

As the premiere cytometry conference convenes in Montréal this May at CYTO 2023, join our team for the first public look at how our single-cell infrastructure platform unlocks the full potential of modern, high-dimensional flow cytometry. Four scientific presentations will highlight the speed, resolution, and scale of Ozette’s core technologies. You can also meet the team members who developed Ozette’s assay-to-insights solutions on the exhibition floor (booth 539) and hear directly from translational science and computational domain experts Cherie Green and Greg Finak in a commercial tutorial for a peek behind the scenes of our new product offerings.

Read More

PSBJ recognizes Ozette CEO Ali Ansary as 2023 40 Under 40 Honoree.

The Puget Sound Business Journal honored Ozette CEO Ali Ansary on its list of the top 40 dynamic leaders under the age of 40 in the business community who are moving the needle for the PNW startup ecosystem by making an impact in business, philanthropy, and their communities. Ali’s leadership and conviction inspire our team every day to remember Ozette’s ultimate goal: To accelerate scientific discovery for new therapies that improve patients’ quality of life and cure disease. Click through to PSBJ to read the full profile on Ali and Ozette, available with subscription.

Read More